Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 76, Issue 4, 2006, Pages 230-236

  Zhao, Weizhi ^a   Mosley, Bridget S ^a   Cleves, Mario A ^a   Melnyk, Stepan ^a   James, S Jill ^a   Hobbs, Charlotte A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Folate; Glutathione; Homocysteine; Maternal biomarkers; Methionine; Neural tube defects

Indexed keywords

ADENOSINE; BIOLOGICAL MARKER; CYANOCOBALAMIN; CYSTEINE; FOLIC ACID; GLUTATHIONE; HOMOCYSTEINE; METHIONINE; PYRIDOXINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; TRACE ELEMENT;

ADULT; AMINO ACID METABOLISM; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENETIC ANALYSIS; GLUTATHIONE METABOLISM; HOMOCYSTEINE METABOLISM; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; MATERNAL PLASMA; METABOLITE; METHYLATION; NEURAL TUBE DEFECT; NORMAL HUMAN; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

ADULT; ALCOHOL DRINKING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GLUTATHIONE; HUMANS; INFANT, NEWBORN; MATERNAL AGE; NEURAL TUBE DEFECTS; PREGNANCY; SMOKING;

EID: 33646235631     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20240     Document Type: Article

References (59)

1. Anonymous. 1998. Lowering blood homocysteine with folk acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. BMJ 316:894-898.
2. Block Dietary Data Systems. 2000. Block 2000 brief food questionnaire. Berkeley, CA: Nutrition Quest, pp. 1-8.
3. Boddie AM, Dedlow ER, Nackashi JA, et al. 2000. Folate absorption in women with a history of neural tube defect-affected pregnancy. Am J Clin Nutr 72:154-158.
4. Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862-877.
5. Castro R, Rivera I, Struys EA, et al. 2003. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 49:1292-1296.
6. Cikot RJ, Steegers-Theunissen RP, Thomas CM, et al. 2001. Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr 85:49-58.
7. Czeizel AE, Puho E, Banhidy F, Acs N. 2004. Oral pyridoxine during pregnancy: potential protective effect for cardiovascular malformations. Drug RD 5:259-269.
8. Davis SD, Nelson T, Shepard TH. 1970. Teratogenicity of vitamin B6 deficiency: omphalocele, skeletal and neural defects, and splenic hypoplasia. Science 169:1329-1330.
9. Ehrlich M. 2003. Expression of various genes is controlled by DNA methylation during mammalian development. J Cell Biochem 88:899-910.
10. Finkelstein JD. 1998. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157:540-544.
11. Finnell RH, Spiegelstein O, Wlodarczyk B, et al. 2002. DNA methylation in Folbp1 knockout mice supplemented with folic acid during gestation. J Nutr 132:24575-24613.
12. Groenen PM, van Rooij IA, Peer PG, et al. 2004. Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. Am J Obstet Gynecol 191:11-17.
13. Harmon DL, Woodside JV, Yarnell JW, et al. 1996. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM 89:571-577.
14. Healton EB, Savage DG, Brust JC, et al. 1991. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 70:229-245.
15. Herbert V, Das KC. 1994. Folic acid and vitamin B-12. In: Modern nutrition in health and disease. In: Shils ME, Olson JA, editors. Philadelphia: Lea and Bebiger, pp. 402-425.
16. Hobbs CA, Cleves MA, Melnyk S, et al. 2005a. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr 81:147-153.
17. Hobbs CA, Cleves MA, Zhao W, et al. 2005b. Congenital heart defects and maternal biomarkers of oxidative stress. Am J Clin Nutr 82:598-604.
18. Honein MA, Paulozzi LJ, Mathews TJ, et al. 2001. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285:2981-2986.
19. Huang RF, Hsu YC, Lin HL, Yang FL. 2001. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr 131:33-38.
20. Ishibashi M, Akazawa S, Sakamaki H, et al. 1997. Oxygen-induced embryopathy and the significance of glutathione-dependent antioxidant system in the rat embryo during early organogenesis. Free Radic Biol Med 22:447-454.
21. James SJ, Cutler P, Melnyk S, et al. 2004. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611-1617.
22. Kapusta L, Haagmans ML, Steegers EA, et al. 1999. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 135:773-774.
23. Kirke PN, Molloy AM, Burke H, et al. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. QJM 86:703-708.
24. Kruger WD, Evans AA, Wang L, et al. 2000. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab 70:53-60.
25. Lawrence JM, Watkins ML, Ershoff D, et al. 2003. Design and evaluation of interventions promoting periconceptional multivitamin use. Am J Prev Med 25:17-24.
26. Leklem JE, Reynolds RD. 1988. Challenges and direction in the search for clinical applications of vitamin B6. In: Leklem JE, Reynolds RD, editors. Current topics in nutrition and disease. New York: Alan R. Liss. pp. 437-454.
27. Lequeu B, Guilland JC, Klepping J. 1985. Measurement of plasma pyridoxal 5′-phosphate by combination of an enzymatic assay with high-performance liquid chromatography/electrochemistry. Anal Biochem 149:296-300.
28. Lindenbaum J, Healton EB, Savage DG, et al. 1988. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 318:1720-1728.
29. Lindenbaum J, Rosenberg IH, Wilson PW, et al. 1994. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 60:2-11.
30. Mills JL, Tuomilehto J, Kai FY, et al. 1992. Maternal vitamin levels during pregnancies producing infants with neural tube defects. J Pediatr 120:863-871.
31. Mills JL, Mcpartlin JM, Kirke PN, et al. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151.
32. Munger RG, Sauberlich HE, Corcoran C, et al. 2004. Maternal vitamin B-6 and folate status and risk of oral cleft birth defects in the Philippines. Birth Defects Res Part A Clin Mol Teratol 70:464-471.
33. National Birth Defects Prevention Network. 2004. 2004 Congenital malformations surveillance report: a report from the National Birth Defects Prevention Network. In: Mirkes PE, editor. Birth Defects Res A Clin Mol Teratol 70:553-772.
34. Nemeth I, Orvos H, Boda D. 2001. Blood glutathione redox status in gestational hypertension. Free Radic Biol Med 30:715-721.
35. Perna AF, Ingrosso D, Lombardi C, et al. 2003. Possible mechanisms of homocysteine toxicity. Kidney Int May;(84) Suppl:S137-S140.
36. Ray JG, Blom HJ. 2003. Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM 96:289-295.
37. Ronnenberg AG, Goldman MB, Chen D, et al. 2002. Preconception homocysteine and B vitamin status and birth outcomes in Chinese women. Am J Clin Nutr 76:1385-1391.
38. Rosenquist TH, Ratashak SA, Selhub J. 1996. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 93:15227-15232.
39. Rothenberg SP, da Costa MP, Sequeira JM, et al. 2004. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med 350:134-142.
40. Sakamaki H, Akazawa S, Ishibashi M, et al. 1999. Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 48:1138-1144.
41. Shaw GM, Todoroff K, Schaffer DM, Selvin S. 1999. Periconceptional nutrient intake and risk for neural tube defect-affected pregnancies. Epidemiology 10:711-716.
42. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. 1998. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Institute of Medicine. Washington, DC: National Academy Press, pp. 425.
43. Steegers-Theunissen RP, Boers GH, Trijbels FJ, et al. 1994. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43:1475-1480.
44. Tamura T, Munger RG, Corcoran C, et al. 2005. Plasma zinc concentrations of mothers and the risk of nonsyndromic oral clefts in their children: a case-control study in the Philippines. Birth Defects Res A Clin Mol Teratol 73:612-616.
45. Thorand B, Pietrzik K, Prinz-Langenohl R, et al. 1996. Maternal and fetal serum and red blood cell folate and vitamin B12 concentrations in pregnancies affected by neural tube defects. Z Geburtshilfe Neonatol 200:176-180.
46. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
47. van der Put NM, Blom HJ. 2000. Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur J Obstet Gynecol Reprod Biol 92:57-61.
48. van der Put NM, van Staaten HW, Trijbels EJ, Blom HJ. 2001. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med (Maywood) 226:243-270.
49. van Rooij IA, Swinkels DW, Blom HJ, et al. 2003. Vitamin and homocysteine status of mothers and infants and the risk of nonsyndromic orofacial clefts. Am J Obstet Gynecol 189:1155-1160.
50. Wald NJ, Hackshaw AK, Stone R, Sourial NA. 1996. Blood folic acid and vitamin B12 in relation to neural tube defects. Br J Obstet Gynaecol 103:319-324.
51. Walker MC, Smith GN, Perkins SL, et al. 1999. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 180:660-664.
52. Welch GN, Upchurch GR Jr, Farivar RS, et al. 1998. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos 2. Proc Assoc Am Physicians 110:22-31.
53. Willett W, Stampfer M. 1998. Implications of total energy intake for epidemiologic analysis. In: Willett W, editor. Nutritional epidemiology. New York: Oxford University Press, pp. 273-301.
54. Williams LJ, Mai CT, Edmonds LD, et al. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66:33-39.
55. Williams LJ, Rasmussen SA, Flores A, et al. 2005. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 116:580-586.
56. Wong WY, Eskes TK, Kuijpers-Jagtman AM, et al. 1999. Nonsyndromic orofacial clefts: association with maternal hyperhomocysteinemia. Teratology 60:253-257.
57. Wright ME. 1995. A case-control study of maternal nutrition and neural tube defects in Northern Ireland. Midwifery 11:146-152.
58. Yi P, Melnyk S, Pogribna M, et al. 2000. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275:29318-29323.
59. Yoon PW, Rasmussen SA, Lynberg MC, et al. 2001. The National Birth Defects Prevention Study. Public Health Rep 116(Suppl 1):32-40.